<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T10:56:11Z</responseDate>
  <request identifier="oai:figshare.com:article/34023346" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34023346</identifier>
        <datestamp>2026-09-29T11:07:45Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_15</setSpec>
        <setSpec>category_16</setSpec>
        <setSpec>category_24</setSpec>
        <setSpec>category_45</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_122</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>High-Altitude
Exposure: Effects on Cognitive Performance,
Neurovascular Mechanisms, and Mitigation Strategies</dc:title>
          <dc:creator>Qianli Dong (9035567)</dc:creator>
          <dc:creator>Haonan Li (1493827)</dc:creator>
          <dc:creator>Yifan Xu (87249)</dc:creator>
          <dc:creator>Yi Zhang (9093)</dc:creator>
          <dc:creator>Yingfeng Gao (6188495)</dc:creator>
          <dc:creator>Zhiying Wu (5349284)</dc:creator>
          <dc:creator>Chunxiang Ye (590012)</dc:creator>
          <dc:creator>Jicheng Gong (674131)</dc:creator>
          <dc:creator>Tong Zhu (8079)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Neuroscience</dc:subject>
          <dc:subject>Physiology</dc:subject>
          <dc:subject>Evolutionary Biology</dc:subject>
          <dc:subject>Sociology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Mental Health</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>∼ 50 meters</dc:subject>
          <dc:subject>serum analysis revealed</dc:subject>
          <dc:subject>move toward baseline</dc:subject>
          <dc:subject>mitigate neurocognitive risks</dc:subject>
          <dc:subject>derived neurotrophic factor</dc:subject>
          <dc:subject>5 percentage points</dc:subject>
          <dc:subject>3600 – 5000</dc:subject>
          <dc:subject>neurovascular measures tended</dc:subject>
          <dc:subject>ml compensatory rise</dc:subject>
          <dc:subject>mediation analyses suggested</dc:subject>
          <dc:subject>like protein 1</dc:subject>
          <dc:subject>findings provide evidence</dc:subject>
          <dc:subject>crtt errors increased</dc:subject>
          <dc:subject>mitigation strategies travel</dc:subject>
          <dc:subject>stroop errors increased</dc:subject>
          <dc:subject>11 – 2</dc:subject>
          <dc:subject>stroop errors</dc:subject>
          <dc:subject>findings suggested</dc:subject>
          <dc:subject>signal increased</dc:subject>
          <dc:subject>neurovascular mechanisms</dc:subject>
          <dc:subject>ml increase</dc:subject>
          <dc:subject>present findings</dc:subject>
          <dc:subject>1 pg</dc:subject>
          <dc:subject>upon ascent</dc:subject>
          <dc:subject>subsequently returned</dc:subject>
          <dc:subject>significant direction</dc:subject>
          <dc:subject>sea level</dc:subject>
          <dc:subject>point increase</dc:subject>
          <dc:subject>oxygen supplementation</dc:subject>
          <dc:subject>neural activity</dc:subject>
          <dc:subject>larger cohorts</dc:subject>
          <dc:subject>l .))</dc:subject>
          <dc:subject>l .)</dc:subject>
          <dc:subject>indirect association</dc:subject>
          <dc:subject>hypobaric hypoxia</dc:subject>
          <dc:subject>behavioral changes</dc:subject>
          <dc:subject>bdnf ).</dc:subject>
          <dc:subject>approximately 10</dc:subject>
          <dc:subject>altitude exposure</dc:subject>
          <dc:subject>21 ),</dc:subject>
          <dc:subject>16 ).</dc:subject>
          <dc:description>Travel to and work at high altitudes expose individuals
to hypobaric
hypoxia; however, its effects on neural activity and function remain
insufficiently understood. Here, we present findings from a longitudinal
panel study incorporating oxygen supplementation tests in individuals
who traveled from low altitude (Beijing, ∼50 meters above sea
level (m.a.s.l.)) to high altitude (Xizang, 3600–5000 m.a.s.l.)
and subsequently returned to low altitude. Upon ascent from low to
high altitude, peripheral oxygen saturation decreased by approximately
10.5 percentage points, accompanied by a 2.48-point increase in Acute
Mountain Sickness symptom scores. The odds of CRTT errors increased
at Visit 2 (OR = 3.21), and the odds of Stroop errors increased at
Visits 3–5 (ORs of 2.11–2.16). Additionally, the relative
cerebral deoxygenated hemoglobin (ΔHbR) signal increased by
3.0 μM·mm during tests. Serum analysis revealed a 390.1
pg/mL increase in chitinase-3-like protein 1 (CHI3L1), indicating
inflammatory activation, and a 37.1 pg/mL compensatory rise in brain-derived
neurotrophic factor (BDNF). Mediation analyses suggested an indirect
association of high-altitude exposure with Stroop errors through ΔHbR.
Furthermore, our findings suggested that a few minutes of oxygen supplementation
at high altitude may improve cerebral oxygenation, with behavioral
changes in a favorable but non-significant direction, while cognitive
and neurovascular measures tended to move toward baseline after return
to low altitude. These findings provide evidence that high-altitude
exposure is associated with significant yet potentially reversible
neurocognitive effects, underscoring the need for confirmation in
larger cohorts and further evaluation of strategies to mitigate neurocognitive
risks.</dc:description>
          <dc:date>2026-09-29T00:00:00Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.1021/envhealth.6c00248.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/High-Altitude_Exposure_Effects_on_Cognitive_Performance_Neurovascular_Mechanisms_and_Mitigation_Strategies/34023346</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
